Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review

被引：0
|
作者：
María Buti
Itziar Oyagüez
Virginia Lozano
Miguel A. Casado
机构：
[1] Hospital General Universitario Valle de Hebron,Servicio de Hepatologia
[2] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd) del Instituto de Salud Carlos III,undefined
[3] Pharmacoeconomics & Outcomes Research Iberia,undefined
来源：
PharmacoEconomics | 2013年 / 31卷
关键词：
Chronic Hepatitis; Economic Evaluation; Tiotropium; Entecavir; Probabilistic Sensitivity Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 75
页数：12
相关论文
共 50 条
  • [1] Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B A Systematic Review
    Buti, Maria
    Oyagueez, Itziar
    Lozano, Virginia
    Casado, Miguel A.
    [J]. PHARMACOECONOMICS, 2013, 31 (01) : 63 - 75
  • [2] Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: A systematic review of economic evidence
    Sun, Xin
    Qin, Wen-Xia
    Li, You-Ping
    Jiang, Xu-Hua
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 (09) : 1369 - 1377
  • [3] COST-EFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B: A SYSTEMATIC REVIEW
    Chen, W.
    Tang, Z.
    Wang, X.
    Li, J.
    Luo, Z.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A805 - A805
  • [4] First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
    Mak, Lung-Yi
    Wong, Danny Ka-Ho
    Cheung, Ka-Shing
    Seto, Wai-Kay
    Fung, James
    Yuen, Man-Fung
    [J]. BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [5] First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients
    Lung-Yi Mak
    Danny Ka-Ho Wong
    Ka-Shing Cheung
    Wai-Kay Seto
    James Fung
    Man-Fung Yuen
    [J]. BMC Gastroenterology, 21
  • [6] Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
    Buti, Maria
    Brosa, Max
    Casado, Miguel A.
    Rueda, Magdalena
    Esteban, Rafael
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 640 - 646
  • [7] Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China
    Dai, Zonglin
    Wong, Irene O. L.
    Xie, Chan
    Xu, Wenxiong
    Xiang, Yu
    Peng, Liang
    Lau, Eric H. Y.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 300.e1 - 300.e8
  • [8] Cost-effectiveness analysis of antiviral therapies for chronic hepatitis B in Taiwan
    Chan, KA
    Pwu, RF
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 263 - 263
  • [9] SERUM HBCRAG PROFILES IN CHRONIC HEPATITIS B PATIENTS TREATED WITH FIRST-LINE ORAL ANTIVIRAL THERAPY
    Mak, Lung Yi
    Wong, Danny Ka Ho
    Seto, Wai-Kay
    Fung, James
    Lai, Ching Lung
    Yuen, Man Fung
    [J]. HEPATOLOGY, 2019, 70 : 292A - 292A
  • [10] Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study
    Kathryn Coyle
    Doug Coyle
    Julie Blouin
    Karen Lee
    Mohammed F. Jabr
    Khai Tran
    Lisa Mielniczuk
    John Swiston
    Mike Innes
    [J]. PharmacoEconomics, 2016, 34 : 509 - 520
12345